Published in AAPS J on April 10, 2010
Dried blood spots and sparse sampling: a practical approach to estimating pharmacokinetic parameters of caffeine in preterm infants. Br J Clin Pharmacol (2013) 0.88
Analysis of tacrolimus and creatinine from a single dried blood spot using liquid chromatography tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci (2013) 0.82
Implementing dried blood spot sampling for clinical pharmacokinetic determinations: considerations from the IQ Consortium Microsampling Working Group. AAPS J (2014) 0.81
Structure-guided design of novel Trypanosoma brucei Methionyl-tRNA synthetase inhibitors. Eur J Med Chem (2016) 0.80
An Integrated Strategy for Implementation of Dried Blood Spots in Clinical Development Programs. AAPS J (2016) 0.79
Determination of efavirenz in human dried blood spots by reversed-phase high-performance liquid chromatography with UV detection. Ther Drug Monit (2013) 0.79
Using dried blood spot sampling to improve data quality and reduce animal use in mouse pharmacokinetic studies. J Am Assoc Lab Anim Sci (2015) 0.79
What a drop can do: dried blood spots as a minimally invasive method for integrating biomarkers into population-based research. Demography (2007) 4.26
Use of filter paper for the collection and analysis of human whole blood specimens. J Nutr (2001) 3.85
Influence of route of administration on drug availability. J Pharm Sci (1972) 2.02
Physiologically based pharmacokinetic modeling 1: predicting the tissue distribution of moderate-to-strong bases. J Pharm Sci (2005) 1.95
Dried blood spot sampling in combination with LC-MS/MS for quantitative analysis of small molecules. Biomed Chromatogr (2010) 1.70
Dried blood spots as a sample collection technique for the determination of pharmacokinetics in clinical studies: considerations for the validation of a quantitative bioanalytical method. Anal Chem (2009) 1.38
Dried blood spot methods in therapeutic drug monitoring: methods, assays, and pitfalls. Ther Drug Monit (2009) 1.35
Mechanistic approaches to volume of distribution predictions: understanding the processes. Pharm Res (2007) 1.18
Influence of hematocrit and localisation of punch in dried blood spots on levels of amino acids and acylcarnitines measured by tandem mass spectrometry. Clin Chim Acta (2006) 1.06
Discovery stage pharmacokinetics using dried blood spots. J Chromatogr B Analyt Technol Biomed Life Sci (2004) 1.04
Physiologically based pharmacokinetics of cyclosporine A: extension to tissue distribution kinetics in rats and scale-up to human. J Pharmacol Exp Ther (1998) 1.03
Application of dried blood spots combined with HPLC-MS/MS for the quantification of acetaminophen in toxicokinetic studies. J Chromatogr B Analyt Technol Biomed Life Sci (2008) 0.99
Therapeutic drug monitoring of tacrolimus with the dried blood spot method. J Pharm Biomed Anal (2006) 0.97
Quantification of etravirine (TMC125) in plasma, dried blood spots and peripheral blood mononuclear cell lysate by liquid chromatography tandem mass spectrometry. J Pharm Biomed Anal (2008) 0.96
Saturable binding of cyclosporin A to erythrocytes: estimation of binding parameters in renal transplant patients and implications for bioavailability assessment. Pharm Res (1988) 0.95
Nonlinear relationship between plasma and red blood cell pharmacokinetics of chlorthalidone in man. J Pharmacokinet Biopharm (1977) 0.90
Physiologically based pharmacokinetic study on a cyclosporin derivative, SDZ IMM 125. J Pharmacokinet Biopharm (1994) 0.89
Plasma protein binding of tacrolimus in humans. J Pharm Sci (1993) 0.88
Effects of some hematological parameters on whole blood tacrolimus concentration measured by two immunoassay-based analytical methods. Clin Biochem (2005) 0.86
Application of dried blood spots combined with high-performance liquid chromatography coupled with electrospray ionisation tandem mass spectrometry for simultaneous quantification of vincristine and actinomycin-D. Anal Bioanal Chem (2009) 0.86
Therapeutic drug monitoring of everolimus using the dried blood spot method in combination with liquid chromatography-mass spectrometry. J Pharm Biomed Anal (2008) 0.84
Study of dried blood spots technique for the determination of dextromethorphan and its metabolite dextrorphan in human whole blood by LC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci (2009) 0.83
On-line desorption of dried blood spot: A novel approach for the direct LC/MS analysis of micro-whole blood samples. J Pharm Biomed Anal (2009) 0.81
Monitoring of cyclosporine concentrations by using dry blood-spot samples. J Clin Lab Anal (1991) 0.78